US Edition
The FDA’s 7-OH Crackdown Isn’t About Safety. It’s About Power.
On July 29, 2025, the FDA announced a plan to restrict 7-hydroxymitragynine (7-OH) a naturally occurring metabolite found in kratom—citing its potential for abuse and the growing presence of “youth-targeted” products. The agency’s language was dramatic: 7-OH was framed as…
1 Articles
1 Articles
The FDA’s 7-OH Crackdown Isn’t About Safety. It’s About Power.
On July 29, 2025, the FDA announced a plan to restrict 7-hydroxymitragynine (7-OH) a naturally occurring metabolite found in kratom—citing its potential for abuse and the growing presence of “youth-targeted” products. The agency’s language was dramatic: 7-OH was framed as…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
